Summary:
A randomized double-blind, cross-over trial comparing the safety and efficacy of insulin degludec and insulin gargine, with or without oral anti-diabetic treatment in patients with type 2 diabetes.
Qualified Participants Must:
• Be at least 18 years of age
•
Have diabetes type two that is being treated with long acting insulin for at least 26 weeks
Qualified Participants May Receive:
Diabetic supplies including glucometer, test strips, needles, syringes, lab test, study related visits to see the doctor and study staff and compensation for their time and travel.